Hopeful Mesothelioma Research: A Look at One Scientist

Friday, March 13th, 2009

Carl H. June, M.D., a professor of Pathology and Laboratory Medicine and director of Translational Research at Penn’s Abramson Cancer Center, recently led a study that generated altered immune cells that shrank, and in some cases wiped out, large tumors in mice.

“Based on the size of the tumors and the number of cells administered, we estimate that one mesothelin-targeted T cell was able to kill about 40 tumor cells,” said Dr. June.

Clinical trials are being developed to investigate this approach in patients with mesothelioma and ovarian cancer.

To learn more about this remarkable researcher, see his online bio. Also, please look through our website for more detailed information on Mesothelioma, including diagnosis, treatment, clinical trials, doctors and hospitals treating the disease, and your legal options.